Research to Reality: Transformation in Life Sciences
Date:听May 16th & May 17th
Live Event:听9:00 AM 鈥� 12:00 PM EDT
Replay:听9:00 PM 鈥� 12 AM EDT
Agenda
听Tuesday, May 16th 2023 | |||
|---|---|---|---|
Masters of Ceremony:听, Partner, Healthcare and Life Sciences, 乐鱼（Leyu）体育官网 UK听 听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听听, Strategy Partner, Healthcare and Life Sciences, 乐鱼（Leyu）体育官网 UK | |||
| Time | Session | Speaker(s) | 乐鱼（Leyu）体育官网 Host |
9:00 am 鈥� 9:55 am | Session 1: Industry and Economic Outlook | ||
| 听 | 1A: Healthcare Outlook | , Global Head of Healthcare at 乐鱼（Leyu）体育官网 International | |
| 听 | 1B: Economic Outlook | , Chief Economist, 乐鱼（Leyu）体育官网 UK | |
| 听 | 1C: Digital Healthcare Solutions | , Vice President, Head of Digital Healthcare, Sanofi | , Principal, Advisory 乐鱼（Leyu）体育官网 US |
10:00 鈥� 10:55 a.m. | Session 2: Deals, M & A, Alliances | ||
听 | 2A: Connectivity, Trust, Collaboration听鈥� a new way for partnerships | , CEO at UCB 听 | 听 , Global Life Sciences Deal Advisory and Strategy Leader, 乐鱼（Leyu）体育官网 US 听 |
听 | 2B: 听FTC Antitrust Battle with Facebook and the impact on future deals in Life Sciences | , Partner at Goodwin, Co-Chair, Anti-Trust, Goodwin | , PhD, Partner, National Leader Life Sciences, Strategy Consulting, 乐鱼（Leyu）体育官网 US 听 |
11:00 - 11:55 a.m. | Session 3: Advancing ESG Solutions: Initiatives to Support the Health of People and Planet | ||
听 | 3A: Women in Technology | ,听Executive Vice President and Chief Information Officer, Cardinal Health | , Chief Medical Officer, 乐鱼（Leyu）体育官网 UK |
听 | 3B:听Women鈥檚 Health Innovation | , Head of Research and Development, Organon | ,听Chief Medical Officer, 乐鱼（Leyu）体育官网 UK |
听 | 3C: Responsible Sourcing | , SVP & CPO, Becton Dickinson | , Managing Director, Consulting, ESG Leader,听乐鱼（Leyu）体育官网 US |
| 听 | 3D: Health Equity | , Chief Compliance, Quality & Risk Officer, Pfizer, Inc. | , Partner, Audit, 乐鱼（Leyu）体育官网 US |
听
Wednesday, May 17th 2023 | |||
|---|---|---|---|
| Time | Session | Speaker(s) | 乐鱼（Leyu）体育官网 Host |
9:00 am 鈥� 9:55 am | Session 4: Data Science and Technology | ||
听 | 4A: Data as an asset:听Explore how creating a data asset enables competitive differentiation and strategic advantage | , Regional Commercial Director, Janssen Asia Pacific , Director & Data Scientist, Janssen Asia Pacific , LifeScience & Healthcare, Customer Vertical Leader, Clarivate | , Director, Healthcare and Life Sciences, 乐鱼（Leyu）体育官网 Asia Pacific |
| 听 | 4B: 听Customer and employee digital transformation | , Managing Director, Healthcare and Life Sciences, 乐鱼（Leyu）体育官网 US ,听Managing Director, Human Capital Advisory, 乐鱼（Leyu）体育官网 US | |
| 听 | 4C: Avalon: The world's first healthcare metaverse | , Chief Medical Officer, Medical Realities | , Principal Advisory, 乐鱼（Leyu）体育官网 US |
10:00 鈥� 10:55 a.m. | Session 5: Connected Enterprise | ||
听 | 5A:听Data privacy | ,听SVP & Chief Information Security Officer, Pfizer, Inc. | , Cyber in Life Sciences Global Lead, 乐鱼（Leyu）体育官网, UK |
| 听 | 5B:听Innovation in Compliance | ,听Principal, Advisory, Forensic, 乐鱼（Leyu）体育官网 US , Director, Healthcare and Life Sciences Advisory, 乐鱼（Leyu）体育官网 US听 | |
| 听 | 5C: Patient Safety and Quality | , Chief Patient Safety and Quality Officer, Philips | , Principal, Life Sciences Operations Advisory, 乐鱼（Leyu）体育官网 US |
11:00 am 鈥� 11:55 am | Session 6: Future of Life Sciences | ||
听 | 6A: Roadblocks on the path to Precision Medicine | , VP US Oncology Medical Affairs, Johnson & Johnson , Lung Cancer Survivor, KRAS Kickers | 听Managing Director, Healthcare & Life Sciences, 乐鱼（Leyu）体育官网 US |
听 | 6B: The role of the patient in the evolving patient journey of Precision Medicine in Neurodegenerative Diseases | , President, Neuroscience, Johnson & Johnson , Co-Founder and Chief Science Officer at the Alzheimer's Drug Discovery Foundation | ,听MD Managing Director, Life Sciences Deal Advisory and Strategy, 乐鱼（Leyu）体育官网 US |
